Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11 , 1374.
Tjalf ZiemssenMarie GrothVeronika Eva WinkelmannTobias BoppPublished in: Vaccines (2024)
The authors would like to make the following corrections to this published paper [...].